Sleep in patients with primary dystonia: A systematic review on the state of research and perspectives

Sleep Medicine Reviews

Volumn 26, Issue , 2015, Pages 95-107

  Hertenstein, Elisabeth ^a   Tang, Nicole K Y ^b   Bernstein, Celia J ^c   Nissen, Christoph ^a   Underwood, Martin R ^c   Sandhu, Harbinder K ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Dystonia; Pathophysiology; Polysomnography; Self report; Sleep

Indexed keywords

ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA;

ATTRIBUTIONAL BIAS; BECK DEPRESSION INVENTORY; BLEPHAROSPASM; BRAIN FUNCTION; CERVICAL DYSTONIA; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DOPA RESPONSIVE DYSTONIA; DRUG ACTIVITY; DYSTONIA; EPWORTH SLEEPINESS SCALE; FOCAL CERVICAL DYSTONIA; FOCAL CRANIAL DYSTONIA; GCH1 GENE; GENERALISED TORSION DYSTONIA; GENETICS; HUMAN; INFORMATION PROCESSING; INSOMNIA; MEDICAL RESEARCH; MIXED DYSTONIA; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PEER REVIEW; PITTSBURGH SLEEP QUALITY INDEX; POLYSOMNOGRAPHY; PRIMARY DYSTONIA; PUBLICATION; QUALITY OF LIFE; REM SLEEP; REVIEW; SEDATION; SELF REPORT; SEX DIFFERENCE; SLEEP; SLEEP DISORDER; SLEEP QUALITY; SOCIOECONOMICS; SYSTEMATIC REVIEW; TORSION DYSTONIA; COMPLICATION; DYSTONIC DISORDER; PROCEDURES; SLEEP WAKE DISORDERS;

DEPRESSION; DYSTONIC DISORDERS; HUMANS; POLYSOMNOGRAPHY; QUALITY OF LIFE; SLEEP WAKE DISORDERS;

EID: 84946473232     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2015.04.004     Document Type: Review

References (66)

1. Albanese A., Bhatia K., Bressman S.B., Delong M.R., Fahn S., Fung V.S.C., et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013, 28:863-873.
2. LeDoux M.S. Dystonia: phenomenology. Park Relat Disord 2012, 18(Suppl. 1):S162-S164.
3. Defazio G. The epidemiology of primary dystonia: current evidence and perspectives. Eur J Neurol 2010, 17(Suppl. 1):9-14.
4. Zetterberg L., Aquilonius S.-M., Lindmark B. Impact of dystonia on quality of life and health in a Swedish population. Acta Neurol Scand 2009, 119:376-382.
5. Soeder A., Kluger B.M., Okun M.S., Garvan C.W., Soeder T., Jacobson C.E., et al. Mood and energy determinants of quality of life in dystonia. J Neurol 2009, 256:996-1001.
6. Marsh W.A., Monroe D.M., Brin M.F., Gallagher C.J. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. BMC Neurol 2014, 14:91.
7. Ramirez-Castaneda J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: a 20-year follow-up. Toxicon 2014, 90:344-348.
8. Chen S. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins 2012, 4:913-939.
9. Hu W., Stead M. Deep brain stimulation for dystonia. Transl Neurodegener 2014, 3:2.
10. Bjerknes S., Skogseid I.M., Sæhle T., Dietrichs E., Toft M. Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period. PLoS One 2014, 9:e105288.
11. Kupsch A., Benecke R., Müller J., Trottenberg T., Schneider G.-H., Poewe W., et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006, 355:1978-1990.
12. Volkmann J., Wolters A., Kupsch A., Müller J., Kühn A.A., Schneider G.-H., et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 2012, 11:1029-1038.
13. Kuyper D.J., Parra V., Aerts S., Okun M.S., Kluger B.M. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011, 26:1206-1217.
14. Stamelou M., Edwards M.J., Hallett M., Bhatia K.P. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 2012, 135:1668-1681.
15. Ben-Shlomo Y., Camfield L., Warner T. ESDE collaborative group. What are the determinants of quality of life in people with cervical dystonia?. J Neurol Neurosurg Psychiatr 2002, 72:608-614.
16. Page D., Butler A., Jahanshahi M. Quality of life in focal, segmental, and generalized dystonia. Mov Disord 2007, 22:341-347.
17. Mayer G., Jennum P., Riemann D., Dauvilliers Y. Insomnia in central neurologic diseases - occurrence and management. Sleep Med Rev 2011, 15:369-378.
18. Manchikanti L., Singh V., Smith H.S., Hirsch J.A. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 4: observational studies. Pain Physician 2009, 12:73-108.
19. Zeng X., Zhang Y., Kwong J.S.W., Zhang C., Li S., Sun F., et al. The methodological quality assessment tools for pre-clinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015, 8:2-10.
20. Cochrane handbook for systematic reviews of interventions Version 5.1.0 2011, [updated March 2011]. The Cochrane Collaboration, Available from:. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
21. Sforza E., Montagna P., Defazio G., Lugaresi E. Sleep and cranial dystonia. Electroencephalogr Clin Neurophysiol 1991, 79:166-169.
22. Lobbezoo F., Thu T.M., Rémillard G., Montplaisir J.Y., Lavigne G.J. Relationship between sleep, neck muscle activity, and pain in cervical dystonia. Can J Neurol Sci 1996, 23:285-290.
23. Fish D.R., Allen P.J., Sawyers D., Marsden C.D. Sleep spindles in torsion dystonia. Arch Neurol 1990, 47:216-218.
24. Fahn S., Marsden C.D., Calne D.B. Classification and investigation of dystonia. Movement disorders 1987, 332-358. Butterworths, London. 2nd ed. C.D. Marsden, S. Fahn (Eds.).
25. Avanzino L., Martino D., Marchese R., Aniello M.S., Minafra B., Superbo M., et al. Quality of sleep in primary focal dystonia: a case-control study. Eur J Neurol 2010, 17:576-581.
26. Albanese A., Barnes M.P., Bhatia K.P., Fernandez-Alvarez E., Filippini G., Gasser T., et al. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur J Neurol 2006, 13:433-444.
27. Brüggemann N., Stiller S., Tadic V., Kasten M., Münchau A., Graf J., et al. Non-motor phenotype of dopa-responsive dystonia and quality of life assessment. Park Relat Disord 2014, 20:428-431.
28. Rechtschaffen A., Kales A. A manual of standardized terminology, scoring system for sleep stages of human subjects 1968, U.S. Dept. of Health, Education and Welfare, Washington, DC.
29. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
30. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
31. Klingelhoefer L., Martino D., Martinez-Martin P., Sauerbier A., Rizos A., Jost W., et al. Nonmotor symptoms and focal cervical dystonia: observations from 102 patients. Basal Ganglia 2014, 4:117-120.
32. Rios Romenets S., Wolfson C., Galatas C., Pelletier A., Altman R., Wadup L., et al. Validation of the non-motor symptoms questionnaire (NMS-Quest). Park Relat Disord 2012, 18:54-58.
33. Miller K.M., Okun M.S., Fernandez H.F., Jacobson C.E., Rodriguez R.L., Bowers D. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord 2007, 22:666-672.
34. Beck A.T., Steer R., Brown G. Beck depression inventory 1996, The Psychological Corporation, San Antonio, Manual. 2nd ed.
35. Segawa M., Hosaka A., Miyagawa F., Nomura Y., Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976, 14.
36. Gadoth N., Costeff H., Harel S., Lavie P. Motor abnormalities during sleep in patients with childhood hereditary progressive dystonia, and their unaffected family members. Sleep 1989, 12:233-238.
37. Eichenseer S.R., Stebbins G.T., Comella C.L. Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia. Park Relat Disord 2014, 20:405-408.
38. Trotti L.M., Esper C.D., Feustel P.J., Bliwise D.L., Factor S.A. Excessive daytime sleepiness in cervical dystonia. Park Relat Disord 2009, 15:784-786.
39. Paus S., Gross J., Moll-Müller M., Hentschel F., Spottke A., Wabbels B., et al. Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. J Neurol 2011, 258:1835-1840.
40. Silvestri R., De Domenico P., Di Rosa A.E., Bramanti P., Serra S., Di Perri R. The effect of nocturnal physiological sleep on various movement disorders. Mov Disord 1990, 5:8-14.
41. Wein A., Golubev V. Polygraphic analysis of sleep in dystonia musculorum deformans. Waking Sleep 1979, 3:41-50.
42. Jankel W.R., Niedermeyer E., Graf M., Kalsher M. Polysomnography of torsion dystonia. Arch Neurol 1984, 41:1081-1083.
43. Jankel W.R., Niedermeyer E., Graf M., Kalsher M.J. Case report: polysomnographic effects of thalamotomy for torsion dystonia. Neurosurgery 1984, 14:495-498.
44. Feige B., Voderholzer U., Riemann D., Hohagen F., Berger M. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. Clin Neurophysiol 1999, 110:1965-1974.
45. Fish D.R., Sawyers D., Allen P.J., Blackie J.D., Lees A.J., Marsden C.D. The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia. Arch Neurol 1991, 48:210-214.
46. Chahine L.M., Kauta S.R., Daley J.T., Cantor C.R., Dahodwala N. Surface EMG activity during REM sleep in Parkinson's disease correlates with disease severity. Park Relat Disord 2014, 20:766-771.
47. Iranzo A., Stockner H., Serradell M., Seppi K., Valldeoriola F., Frauscher B., et al. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2014, 29:1774-1780.
48. Fish D.R., Sawyers D., Smith S.J., Allen P.J., Murray N.M., Marsden C.D. Motor inhibition from the brainstem is normal in torsion dystonia during REM sleep. J Neurol Neurosurg Psychiatr 1991, 54:140-144.
49. Segawa M. Dopa-responsive dystonia. Handb Clin Neurol 2011, 100:539-557.
50. Cai C., Shi W., Zeng Z., Zhang M., Ling C., Chen L., et al. GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients. PLoS One 2013, 8:e65215.
51. Riemann D., Spiegelhalder K., Feige B., Voderholzer U., Berger M., Perlis M., et al. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010, 14:19-31.
52. Albanese A., Asmus F., Bhatia K.P., Elia A.E., Elibol B., Filippini G., et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol 2011, 18:5-18.
53. Mehta S.H., Morgan J.C., Sethi K.D. Drug-induced movement disorders. Neurol Clin 2015, 33:153-174.
54. Dauvilliers Y., Tafti M., Landolt H.P. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation. Sleep Med Rev 2014, 10.1016/j.smrv.2014.10.006.
55. Buscemi N., Vandermeer B., Friesen C., Bialy L., Tubman M., Ospina M., et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 2007, 22:1335-1350.
56. Aeschbach D., Dijk D.J., Trachsel L., Brunner D.P., Borbély A.A. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 1994, 11:237-244.
57. Kales A., Kales J.D. Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects. J Clin Psychopharmacol 1983, 3:140-150.
58. Bridoux A., Laloux C., Derambure P., Bordet R., Monaca Charley C. The acute inhibition of rapid eye movement sleep by citalopram may impair spatial learning and passive avoidance in mice. J Neural Transm 2013, 120:383-389.
59. Wilson S.J., Nutt D.J. SSRIs and sleep in man. Sleep and sleep disorders 2006, 269-273. Springer, New York City, US.
60. Werle R.W., Takeda S.Y.M., Zonta M.B., Guimarães A.T.B., Teive H.A.G. The physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystonia. Arq Neuropsiquiatr 2014, 72:405-410.
61. Sivertsen B., Krokstad S., Øverland S., Mykletun A. The epidemiology of insomnia: associations with physical and mental health. The HUNT-2 study. J Psychosom Res 2009, 67:109-116.
62. Zhang B., Wing Y.-K. Sex differences in insomnia: a meta-analysis. Sleep 2006, 29:85-93.
63. Tang N.K.Y., Goodchild C.E., Sanborn A.N., Howard J., Salkovskis P.M. Deciphering the temporal link between pain and sleep in a heterogeneous chronic pain patient sample: a multilevel daily process study. Sleep 2012, 35:675-687A.
64. Vitiello M.V., McCurry S.M., Shortreed S.M., Balderson B.H., Baker L.D., Keefe F.J., et al. Cognitive-behavioral treatment for comorbid insomnia and osteoarthritis pain in primary care: the lifestyles randomized controlled trial. J Am Geriatr Soc 2013, 61:947-956.
65. Rybarczyk B., Stepanski E., Fogg L., Lopez M., Barry P., Davis A. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J Consult Clin Psych 2005, 73:1164.
66. Hertenstein E., Thiel N., Lueking M., Kuelz A.K., Schramm E., Spiegelhalder K., et al. Quality of life improvements after acceptance and commitment therapy (ACT) in Nonresponders to cognitive behavioral therapy for primary insomnia (CBT-I). Psychother Psychosom 2014, 83:371-373.